Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$17.76
Market cap
$416.93M
P/E Ratio
15.72
Dividend/share
$0.48
EPS
$1.13
Enterprise value
$467.1M
NRC Health is the leading provider of in-depth customer insights in healthcare.
Highlights
The stock's price to earnings (P/E) is 50% less than its 5-year quarterly average of 31.6 and 39% less than its last 4 quarters average of 25.6
The quick ratio has grown by 43% since the previous quarter but it has declined by 27% year-on-year
National Research's debt has surged by 125% YoY and by 27% QoQ
National Research's equity has decreased by 40% YoY and by 14% QoQ
Key stats
What are the main financial stats of NRC
Market
Valuations
Earnings
Shares outstanding
23.48M
Market cap
$416.93M
Enterprise value
$467.1M
Price to earnings (P/E)
15.72
Price to book (P/B)
12.24
Price to sales (P/S)
2.92
EV/EBIT
12.48
EV/EBITDA
10.77
EV/Sales
3.24
Revenue
$144.15M
Gross profit
$87.78M
Net income
$27.08M
EBIT
$37.42M
EBITDA
$43.35M
Free cash flow
$25.18M
Per share
Balance sheet
Liquidity
EPS
$1.13
EPS diluted
$1.13
Free cash flow per share
$1.06
Book value per share
$1.45
Revenue per share
$6.08
TBVPS
$2.65
Total assets
$131.8M
Total liabilities
$97.18M
Debt
$53.63M
Equity
$34.62M
Working capital
-$23.58M
Debt to equity
1.55
Current ratio
0.47
Quick ratio
0.33
Net debt/EBITDA
1.16
Margins
Efficiency
Dividend
EBITDA margin
30.1%
Gross margin
60.9%
Net margin
18.8%
Operating margin
25.9%
Return on assets
21.9%
Return on equity
67.4%
Return on invested capital
67%
Return on capital employed
42.8%
Return on sales
26%
Dividend yield
2.7%
DPS
$0.48
Payout ratio
42.5%
NRC stock price
How has the National Research stock price performed over time
Intraday
-0.45%
1 week
0.45%
1 month
-7.11%
1 year
-55.5%
YTD
-55.11%
QTD
-22.31%
Financial performance
How have National Research's revenue and profit performed over time
Revenue
$144.15M
Gross profit
$87.78M
Operating income
$37.31M
Net income
$27.08M
Gross margin
60.9%
Net margin
18.8%
NRC's operating income is down by 8% YoY and by 5% QoQ
NRC's net income is down by 7% QoQ and by 6% YoY
National Research's net margin has decreased by 6% QoQ and by 2.6% YoY
National Research's operating margin has decreased by 5% YoY and by 3.7% QoQ
Growth
What is National Research's growth rate over time
Valuation
What is National Research stock price valuation
P/E
15.72
P/B
12.24
P/S
2.92
EV/EBIT
12.48
EV/EBITDA
10.77
EV/Sales
3.24
The stock's price to earnings (P/E) is 50% less than its 5-year quarterly average of 31.6 and 39% less than its last 4 quarters average of 25.6
The EPS has declined by 7% since the previous quarter and by 3.4% year-on-year
National Research's equity has decreased by 40% YoY and by 14% QoQ
NRC's price to book (P/B) is 36% less than its 5-year quarterly average of 19.2 and 35% less than its last 4 quarters average of 18.7
The P/S is 61% lower than the 5-year quarterly average of 7.5 and 43% lower than the last 4 quarters average of 5.1
National Research's revenue has decreased by 3.1% YoY
Efficiency
How efficient is National Research business performance
NRC's return on equity has surged by 66% year-on-year and by 6% since the previous quarter
NRC's return on invested capital is down by 42% year-on-year and by 19% since the previous quarter
The return on assets has declined by 10% since the previous quarter
The return on sales has declined by 4.1% since the previous quarter
Dividends
What is NRC's dividend history
DPS
$0.48
Dividend yield
2.7%
Payout ratio
42.5%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did National Research financials performed over time
NRC's total assets is 36% greater than its total liabilities
National Research's total liabilities has surged by 56% YoY and by 23% QoQ
The quick ratio has grown by 43% since the previous quarter but it has declined by 27% year-on-year
National Research's debt is 55% higher than its equity
National Research's debt has surged by 125% YoY and by 27% QoQ
NRC's debt to equity is up by 48% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.